Myriad: Q1 Earnings Snapshot

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Myriad Genetics Inc. (MYGN) on Wednesday reported a loss of $54.7 million in its first quarter.

The Salt Lake City-based company said it had a loss of 67 cents per share. Losses, adjusted for non-recurring costs and amortization costs, were 21 cents per share.

The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.

The molecular diagnostic company posted revenue of $181.2 million in the period, exceeding Street forecasts. Five analysts surveyed by Zacks expected $171.5 million.

Myriad expects full-year results to range from a loss of 36 cents per share to a loss of 24 cents per share, with revenue in the range of $730 million to $750 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on MYGN at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up